-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Invivo Therapeutics Holdings Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2022.
- Invivo Therapeutics Holdings Corp. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $131K, a 191% increase year-over-year.
- Invivo Therapeutics Holdings Corp. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $529K, a 690% increase year-over-year.
- Invivo Therapeutics Holdings Corp. annual Nonoperating Income (Expense) for 2022 was $160K, a 3100% increase from 2021.
- Invivo Therapeutics Holdings Corp. annual Nonoperating Income (Expense) for 2021 was $5K, a 78.3% decline from 2020.
- Invivo Therapeutics Holdings Corp. annual Nonoperating Income (Expense) for 2020 was $23K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)